Business Card for Fran Waite – Appeals Coordinator – The MAGIC Foundation ...:


Fran Waite – Appeals Coordinator – The MAGIC Foundation
South San Francisco, CA area
Email Avail: 3 Day Free Trial


1 Dna Way
South San Francisco, CA 94080

Tel: (650) 225-1000

Last updated on 2018-01-11


About Fran Waite – Appeals Coordinator – The MAGIC Foundation ...:

Fran Waite – Appeals Coordinator – The MAGIC Foundation ... works as an Fran Waite – Appeals Coordinator – The MAGIC Foundation for Genentech, Inc. at South San Francisco, CA. The company's webpage is http://www.gene.com. For email, phone number and executive profiles for Fran Waite – Appeals Coordinator – The MAGIC Foundation and other executives of Genentech, Inc. at South San Francisco, CA, check Genentech, Inc. at Joesdata.com. Not the Fran Waite – Appeals Coordinator – The MAGIC Foundation ... you are looking for? Do a quick search in our website and find other people named Fran Waite – Appeals Coordinator – The MAGIC Foundation ....
Fran Waite – Appeals Coordinator – The MAGIC Foundation ...'s Work History:
No information available..

Fran Waite – Appeals Coordinator – The MAGIC Foundation ...'s Education:
No information available..

Fran Waite – Appeals Coordinator – The MAGIC Foundation ...'s Co-workers:
As of January 18, 2021, Fran Waite – Appeals Coordinator – The MAGIC Foundation ... has 1358 co-workers under the company name Genentech, Inc. at Joesdata.com.

About Genentech, Inc.:

Genentech, Inc. is located at 1 Dna Way , South San Francisco, CA 94080. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-13 19:18:41
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-13 17:30:39
FDA Approves Subcutaneous Formulation of Actemra for Use in Active Systemic Juvenile Idiopathic Arthritis (SJIA), a Rare Form of Juvenile Arthritis
2018-09-06 19:24:23
Genentech to Present New Data from Its Extensive Lung Cancer Program at the 2018 World Conference on Lung Cancer (WCLC)
2018-08-30 17:30:48
Positive Phase III Results for Genentechs HEMLIBRA (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine
2018-08-13 19:19:15
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-08-13 17:30:37
FDA Grants Breakthrough Therapy Designation for Xolair (Omalizumab) for Food Allergies
2018-07-25 17:42:26
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-25 17:31:17
Genentech Unveils Positive Phase II Results for the First-Ever Eye Implant to Achieve Sustained Delivery of a Biologic Medicine to Treat People With Wet Age-Related Macular Degeneration (AMD)
2018-07-20 18:54:47
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)
2018-07-20 17:30:51
Genentech to Present New Data Demonstrating the Breadth and Depth of Its Alzheimers Program at the Upcoming Alzheimer's Association International Conference (AAIC)

People in the same industry: